martes, 24 de marzo de 2020

AbbVie waives all worldwide restrictions on making generic copies of its Kaletra HIV pill. (STAT Plus)

The Readout
Damian Garde & Meghana Keshavan

More reads

  • Experimental drug out of Emory University to be tried against coronavirus. (Wall Street Journal)
  • Antibiotic resistance: the hidden threat lurking behind Covid-19. (STAT)
  • Leukemia drug from Roche, AbbVie extends survival, study finds. (BioPharma Dive)
  • AbbVie waives all worldwide restrictions on making generic copies of its Kaletra HIV pill. (STAT Plus)

No hay comentarios: